Corcept Therapeutics (CORT) Shares Outstanding (2010 - 2026)

Corcept Therapeutics has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $108.1 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 2.59% year-over-year to $108.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $108.1 million (up 2.59% YoY) and the FY2025 annual result came in at $106.0 million, up 0.81% from the prior year.
• Shares Outstanding (Entity) climbed to $108.1 million in Q2 2026 per CORT's latest filing, from $107.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $108.1 million in Q2 2026 and troughed at $101.6 million in Q1 2023.
• A 5-year average of $105.3 million and a median of $105.3 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) retreated 8.81% in 2022, then gained 2.59% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $107.8 million in 2022, then slipped by 4.11% to $103.4 million in 2023, then climbed by 1.65% to $105.1 million in 2024, then grew by 0.81% to $106.0 million in 2025, then advanced by 2.01% to $108.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $108.1 million, $107.4 million, and $106.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.